| Name | Title | Contact Details |
|---|
Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, leveraging technology from the lab of Nobel laureate Dr. Paul Greengard, for the treatment of neuropsychiatric and neurodegenerative diseases. The Company is developing its lead drug candidate, lumateperone, a first-in-class molecule, which is in Phase 3 clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia, including Alzheimer`s disease. The Company is also utilizing its phosphodiesterase (PDE) platform and other proprietary chemistry platforms to develop drugs for the treatment of CNS and other disorders. The lead compound in the PDE platform, ITI-214, a PDE1 inhibitor is being developed for the treatment of CNS and non-CNS indications.
biopharmservices is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medly Pharmacy is a full-service, digital pharmacy that delivers your prescription medication to you for free, same day, anywhere in New York City and New Jersey. We created a digital experience that makes managing your prescription simple, efficient, and smart for patients and providers.
PGM Plastics Inc. is a Fitchburg, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
97250 Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City.